VolitionRx Ltd (VNRX) stock
VNRXNYSEIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$0.16−0.02 (-10.00%)
Close on Nov 19, 2026Market cap $2.25MP/E –Yield –
VolitionRx shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
VolitionRx's shares outstanding was 9M at Jun 30, 2026. For fiscal 2025 it was 5M, up 23.5% from the year before. Over ten years it grew 23.0% a year on average. The highest annual figure on record is 5M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5M | +23.5% |
| FY2024 | Dec 31, 2024 | 4M | +21.5% |
| FY2023 | Dec 31, 2023 | 4M | +35.3% |
| FY2021 | Dec 31, 2021 | 3M | +16.3% |
| FY2020 | Dec 31, 2020 | 2M | +15.6% |
| FY2019 | Dec 31, 2019 | 2M | +24.8% |
| FY2018 | Dec 31, 2018 | 2M | +18.9% |
| FY2017 | Dec 31, 2017 | 1M | +14.5% |
| FY2016 | Dec 31, 2016 | 1M | +30.0% |
| FY2015 | Dec 31, 2015 | 1M | +32.0% |
| FY2014 | Dec 31, 2014 | 1M | +24.0% |
| FY2013 | Dec 31, 2013 | 1M | +15.7% |
| FY2012 | Dec 31, 2012 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 9M | +78.4% |
| Q1 FY2026 | Mar 31, 2026 | 7M | +42.6% |
| Q4 FY2025 | Dec 31, 2025 | 6M | +29.2% |
| Q3 FY2025 | Sep 30, 2025 | 5M | +23.1% |
| Q2 FY2025 | Jun 30, 2025 | 5M | +24.2% |
| Q1 FY2025 | Mar 31, 2025 | 5M | +17.8% |
| Q4 FY2024 | Dec 31, 2024 | 5M | +74.8% |
| Q3 FY2024 | Sep 30, 2024 | 4M | +65.3% |
| Q2 FY2024 | Jun 30, 2024 | 4M | +56.1% |
| Q1 FY2024 | Mar 31, 2024 | 4M | +60.9% |
| Q4 FY2021 | Dec 31, 2021 | 3M | +10.0% |
| Q3 FY2021 | Sep 30, 2021 | 3M | +13.1% |
| Q2 FY2021 | Jun 30, 2021 | 3M | +22.0% |
| Q1 FY2021 | Mar 31, 2021 | 3M | +23.6% |
| Q4 FY2020 | Dec 31, 2020 | 2M | +18.4% |
| Q3 FY2020 | Sep 30, 2020 | 2M | +17.9% |
| Q2 FY2020 | Jun 30, 2020 | 2M | +11.7% |
| Q1 FY2020 | Mar 31, 2020 | 2M | +13.8% |
| Q4 FY2019 | Dec 31, 2019 | 2M | +16.3% |
| Q3 FY2019 | Sep 30, 2019 | 2M | +21.5% |
| Q2 FY2019 | Jun 30, 2019 | 2M | +29.5% |
| Q1 FY2019 | Mar 31, 2019 | 2M | +32.8% |
| Q4 FY2018 | Dec 31, 2018 | 2M | +33.2% |
| Q3 FY2018 | Sep 30, 2018 | 2M | +23.8% |
| Q2 FY2018 | Jun 30, 2018 | 2M | +13.8% |
| Q1 FY2018 | Mar 31, 2018 | 1M | +4.3% |
| Q4 FY2017 | Dec 31, 2017 | 1M | +2.2% |
| Q3 FY2017 | Sep 30, 2017 | 1M | +12.7% |
| Q2 FY2017 | Jun 30, 2017 | 1M | – |
| Q1 FY2017 | Mar 31, 2017 | 1M | – |
| Q4 FY2016 | Dec 31, 2016 | 1M | – |
| Q3 FY2016 | Sep 30, 2016 | 1M | – |
See a number that looks wrong?